GASTROINTESTINAL PERFORATION side effect
What is GASTROINTESTINAL PERFORATION ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
GASTROINTESTINAL PERFORATION and Recently Reported Side Effects
GASTROINTESTINAL PERFORATION and 15 most Active Side Effect polls
GASTROINTESTINAL PERFORATION and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with GASTROINTESTINAL PERFORATION
ALDACTONE ANGIOMAX AVASTIN AZULFIDINE BEVACIZUMAB BUSULFAN CAPECITABINE DAUNORUBICIN ENBREL ERLOTINIB ESOMEPRAZOLE EXTRANEAL FLUOROURACIL FORTEO FOSAMAX GEMCITABINE GEMZAR HYDROXYCHLOROQUI INDOCIN ISOVORIN IXABEPILONE MIRENA NEUPOGEN NEXAVAR PEMETREXED REMICADE RITUXAN SORAFENIB SUTENT TAXOL TAXOTERE TEMODAL XELODAFluorouracil Side Effects Report #5647426-6
Physician from JAPAN reported FLUOROURACIL problem on Feb 25, 2008. Female patient was diagnosed with colon cancer and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, . FLUOROURACIL dosage: unknown. During the same period patient was treated with BEVACIZUMAB, OXALIPLATIN, CALCIUM LEVOFOLINATE. Patient recovered.
Esomeprazole Side Effects Report #5652956-7
ESOMEPRAZOLE MAGNESIUM problem was reported by a Consumer or non-health professional from on Feb 29, 2008. Female patient, 68 years of age, weighting 116.8 lb, was diagnosed with prophylaxis against gastrointestinal ulcer, osteoarthritis, eczema, lumbar spinal stenosis, hyperlipidaemia, cataract and was treated with ESOMEPRAZOLE MAGNESIUM. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, liver disorder, pyelonephritis, . ESOMEPRAZOLE MAGNESIUM dosage: unknown. During the same period patient was treated with MOBIC, MYSER, OPALMON, LIPITOR, ARTZ DISPO, XYLOCAINE, MUCOSTA, KARY UNI. Patient was hospitalized. Patient recovered.
Avastin Side Effects Report #5657618-8
Pharmacist from UNITED STATES reported AVASTIN problem on Mar 07, 2008. Female patient, weighting 130.0 lb, was diagnosed with breast cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, . AVASTIN dosage: 590MG Q14D IV DRIP. During the same period patient was treated with ONXOL. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5662396-2
SORAFENIB problem was reported by a Physician from ITALY on Mar 10, 2008. Male patient, 59 years of age, weighting 149.9 lb, was diagnosed with pancreatic carcinoma and was treated with SORAFENIB. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, septic shock, . SORAFENIB dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with GEMCITABINE, CISPLATIN. Patient died on 01/30/2008.
Taxol Side Effects Report #5664726-4
Physician from JAPAN reported TAXOL problem on Mar 10, 2008. Female patient, 67 years of age, was diagnosed with uterine cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, white blood cell count decreased, . TAXOL dosage: unknown. During the same period patient was treated with PARAPLATIN, KYTRIL, NASEA, DEXAMETHASONE PHOSPHATE, DIPHENHYDRAMINE, RANITIDINE, SHAKUYAKU. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5673697-6
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Mar 13, 2008. Female patient was diagnosed with ovarian cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, hypokalaemia, hypomagnesaemia, hyponatraemia, septic shock, . BEVACIZUMAB dosage: 803 MG/KG, UNK. During the same period patient was treated with TAXOL, CISPLATIN, ACETAMINOPHEN, SIMETHICONE, AMBIEN, AMLODIPINE, APREPITANT. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5620647-4
Physician from UNITED STATES reported BEVACIZUMAB problem on Feb 01, 2008. Female patient was diagnosed with ovarian cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, hypokalaemia, hypomagnesaemia, hyponatraemia, septic shock, . BEVACIZUMAB dosage: 803 MG/KG, UNK. During the same period patient was treated with TAXOL, CISPLATIN, ACETAMINOPHEN, SIMETHICONE, AMBIEN, AMLODIPINE, APREPITANT. Patient was hospitalized. Patient recovered.
Avastin Side Effects Report #5639601-1
AVASTIN problem was reported by a Physician from UNITED KINGDOM on May 30, 2007. Male patient was diagnosed with colon cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, sepsis, . AVASTIN dosage: 480 MG, UNK. During the same period patient was treated with XELODA. Patient died on 03/10/2007.
Nexavar Side Effects Report #5645281-1
Physician from BELGIUM reported NEXAVAR problem on Feb 25, 2008. Male patient, 60 years of age, was diagnosed with metastases to peritoneum, metastases to central nervous system and was treated with NEXAVAR. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, peritonitis, . NEXAVAR dosage: unknown. During the same period patient was treated with CORTISONE. Patient was hospitalized. Patient died on 01/31/2008.
Isovorin Side Effects Report #5602097-X
ISOVORIN problem was reported by a Health Professional from JAPAN on Jan 16, 2008. Female patient, 54 years of age, was diagnosed with rectal cancer metastatic and was treated with ISOVORIN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, peritonitis, rectal perforation, . ISOVORIN dosage: 100 MG. During the same period patient was treated with FLUOROURACIL, AVASTIN, ELPLAT. Patient recovered.
Capecitabine Side Effects Report #5506438-3
Physician from UNITED STATES reported CAPECITABINE problem on Oct 13, 2007. Female patient, 66 years of age, weighting 174.8 lb, was diagnosed with colon cancer and was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, . CAPECITABINE dosage: 500 MG, BID. During the same period patient was treated with BEVACIZUMAB, OXALIPLATIN. Patient was hospitalized and became disabled. Patient died on 08/25/2007.
Extraneal Side Effects Report #5509906-3
EXTRANEAL problem was reported by a Consumer or non-health professional from FRANCE on Oct 30, 2007. Female patient, 36 years of age, was diagnosed with peritoneal dialysis and was treated with EXTRANEAL. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, peritonitis, sclerosing encapsulating peritonitis, . EXTRANEAL dosage: unknown. During the same period patient was treated with DIANEAL, NUTRINEAL NOS WITH AMINO ACIDS, FRESENIUS ISO, CELIPROLOL, EUPRESSYL. Patient was hospitalized. Patient recovered.
Pemetrexed Side Effects Report #5510217-0
Physician from JAPAN reported PEMETREXED problem on Oct 25, 2007. Male patient, weighting 103.6 lb, was diagnosed with pleural mesothelioma, vitamin supplementation, cancer pain and was treated with PEMETREXED. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, stress cardiomyopathy, . PEMETREXED dosage: 740 MG, OTHER. During the same period patient was treated with CISPLATIN, PANVITAN, METHYCOBAL, GOODMIN, POSTERISANTE, OXYCONTIN, MAGNESIUM OXIDE. Patient was hospitalized. Patient died on 08/31/2007.
Extraneal Side Effects Report #5517524-6
EXTRANEAL problem was reported by a Consumer or non-health professional from FRANCE on Nov 02, 2007. Male patient, 80 years of age, was diagnosed with peritoneal dialysis and was treated with EXTRANEAL. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, peritoneal infection, sclerosing encapsulating peritonitis, . EXTRANEAL dosage: unknown. During the same period patient was treated with DIANEAL PD, ATENOLOL, PHYSIONEAL. Patient died on 06/01/2007.
Aldactone Side Effects Report #5523641-7
Physician from JAPAN reported ALDACTONE problem on Nov 20, 2007. Female patient was diagnosed with rectal cancer metastatic and was treated with ALDACTONE. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, haemolytic anaemia, leukopenia, . ALDACTONE dosage: unknown. During the same period patient was treated with LASIX, FAMOTIDINE, NAPROXEN, BEVACIZUMAB, ISOVORIN, IRINOTECAN, FLUOROURACIL, OXALIPLATIN. Patient recovered.
Taxol Side Effects Report #5530270-8
TAXOL problem was reported by a Health Professional from JAPAN on Nov 28, 2007. Male patient, 74 years of age, was diagnosed with lung adenocarcinoma and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, septic shock, . TAXOL dosage: unknown. During the same period patient was treated with PARAPLATIN. Patient recovered.
Pemetrexed Side Effects Report #5475958-2
Physician from JAPAN reported PEMETREXED problem on Sept 27, 2007. Male patient, weighting 103.6 lb, was diagnosed with pleural mesothelioma, cancer pain and was treated with PEMETREXED. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, stress cardiomyopathy, . PEMETREXED dosage: unknown. During the same period patient was treated with CISPLATIN, GOODMIN, POSTERISANTE, OXYCONTIN, MAGNESIUM OXIDE. Patient died on 08/30/2007.
Temodal Side Effects Report #5445945-9
TEMODAL problem was reported by a Physician from JAPAN on Aug 30, 2007. Male patient, 67 years of age, weighting 110.2 lb, was diagnosed with anaplastic astrocytoma and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, neutrophil count decreased, septic shock, white blood cell count increased, . TEMODAL dosage: 120 MG/M2; QD; PO, 120 MG/M2; QD; PO. During the same period patient was treated with BAKTAR, GLYCEOL, DECADRON, NAUZELIN, MAGMITT, FAMOTIDINE. Patient was hospitalized. Patient died.
Bevacizumab Side Effects Report #5453904-5
Physician from UNITED STATES reported BEVACIZUMAB problem on Sept 05, 2007. Female patient was diagnosed with ovarian cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, hypokalaemia, hypomagnesaemia, hyponatraemia, septic shock, . BEVACIZUMAB dosage: 803 MG/KG, UNK. During the same period patient was treated with TAXOL, CISPLATIN, ACETAMINOPHEN, SIMETHICONE, AMBIEN, AMLODIPINE, APREPITANT. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #5406408-X
RITUXAN problem was reported by a Consumer or non-health professional from GERMANY on July 30, 2007. Male patient, weighting 178.6 lb, was diagnosed with rheumatoid arthritis and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, . RITUXAN dosage: unknown. During the same period patient was treated with PREDNISOLONE, SEVREDOL, FENTANYL TRANSDERMAL SYSTEM. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #5407073-8
Consumer or non-health professional from UNITED KINGDOM reported RITUXAN problem on July 30, 2007. Male patient, weighting 178.6 lb, was diagnosed with rheumatoid arthritis and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, myocardial infarction, . RITUXAN dosage: unknown. During the same period patient was treated with PREDNISOLONE, SEVREDOL, FENTANYL. Patient was hospitalized. Patient recovered.
Capecitabine Side Effects Report #5420909-X
CAPECITABINE problem was reported by a Physician from UNITED STATES on Aug 10, 2007. Female patient, 66 years of age, was diagnosed with colon cancer and was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, . CAPECITABINE dosage: unknown. During the same period patient was treated with BEVACIZUMAB, OXALIPLATIN. Patient was hospitalized and became disabled. Patient recovered.
Gemcitabine Side Effects Report #5422553-7
Physician from JAPAN reported GEMCITABINE problem on Aug 16, 2007. Female patient, 67 years of age, weighting 99.21 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with GEMCITABINE. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, malignant ascites, malignant neoplasm progression, subileus, . GEMCITABINE dosage: 1000 MG/M2, OTHER. Patient was hospitalized. Patient died on 02/16/2007.
Taxol Side Effects Report #5780020-5
TAXOL problem was reported by a Physician from JAPAN on June 17, 2008. Female patient, 64 years of age, was diagnosed with peritoneal carcinoma and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, . TAXOL dosage: unknown. During the same period patient was treated with PARAPLATIN, MAGNESIUM OXIDE, NAUZELIN, LOXONIN. Patient died on 06/14/2008.
Taxol Side Effects Report #5786508-5
Physician from JAPAN reported TAXOL problem on June 23, 2008. Female patient, 74 years of age, was diagnosed with peritoneal carcinoma and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, . TAXOL dosage: unknown. During the same period patient was treated with PARAPLATIN, MAGNESIUM OXIDE, NAUZELIN, LOXONIN. Patient died on 06/14/2008.
Erlotinib Side Effects Report #5797861-0
ERLOTINIB problem was reported by a Health Professional from JAPAN on June 13, 2008. Male patient, 62 years of age, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, . ERLOTINIB dosage: (150 MG,QD), ORAL. Patient was hospitalized. Patient recovered.
Taxol Side Effects Report #5725977-3
Health Professional from JAPAN reported TAXOL problem on Apr 28, 2008. Male patient, 73 years of age, was diagnosed with lung neoplasm malignant and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, ileus, sepsis, . TAXOL dosage: unknown. During the same period patient was treated with PARAPLATIN. Patient was hospitalized. Patient died on 04/25/2008.
Bevacizumab Side Effects Report #5726473-X
BEVACIZUMAB problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 18, 2008. Female patient, weighting 91.27 lb, was diagnosed with breast cancer metastatic and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, . BEVACIZUMAB dosage: 620 MG, Q3W. During the same period patient was treated with VOLTAREN, ACETAMINOPHEN, MORPHINE, PEVARYL, STILNOX, RESYL PLUS, FORTECORTIN. Patient was hospitalized. Patient died on 04/06/2008.
Nexavar Side Effects Report #5732716-9
Physician from ITALY reported NEXAVAR problem on May 06, 2008. Male patient, 59 years of age, weighting 149.9 lb, was diagnosed with pancreatic carcinoma and was treated with NEXAVAR. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, septic shock, . NEXAVAR dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with GEMCITABINE, CISPLATIN. Patient died on 01/30/2008.
Nexavar Side Effects Report #5737884-0
NEXAVAR problem was reported by a Physician from BELGIUM on May 08, 2008. Male patient, 60 years of age, was diagnosed with metastases to peritoneum, metastases to central nervous system and was treated with NEXAVAR. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, peritonitis, . NEXAVAR dosage: unknown. During the same period patient was treated with CORTISONE. Patient was hospitalized. Patient died on 01/31/2008.
Neupogen Side Effects Report #5751095-4
Health Professional from SPAIN reported NEUPOGEN problem on May 26, 2008. Male patient, weighting 200.6 lb, was treated with NEUPOGEN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, . NEUPOGEN dosage: unknown. During the same period patient was treated with SOLU MODERIN, ZOFRAN, PRIMPERAN, EMCONCOR, ADIRO, DUPHALAC, LEUCOVORIN CALCIUM. Patient died on 04/01/2008.
Indocin Side Effects Report #5674350-5
INDOCIN I problem was reported by a Physician from UNITED STATES on Nov 21, 2007. Female patient was diagnosed with patent ductus arteriosus, prophylaxis and was treated with INDOCIN I. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, . INDOCIN I dosage: 0.1 MG/KG;. During the same period patient was treated with INDOCIN I, SURFACTANT. Patient recovered.
Indocin Side Effects Report #5674351-7
Physician from UNITED STATES reported INDOCIN I problem on Nov 21, 2007. Female patient was diagnosed with patent ductus arteriosus, prophylaxis and was treated with INDOCIN I. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, haemorrhage intracranial, . INDOCIN I dosage: 0.1 MG/KG;. During the same period patient was treated with INDOCIN I, DOPAMINE, HYDROCORTISONE, SURFACTANT. Patient recovered.
Isovorin Side Effects Report #5706262-2
ISOVORIN problem was reported by a Health Professional from JAPAN on Apr 04, 2008. Female patient was treated with ISOVORIN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, . ISOVORIN dosage: unknown. During the same period patient was treated with AVASTIN, ELPLAT, FLUOROURACIL. Patient recovered.
Isovorin Side Effects Report #5713133-4
Health Professional from JAPAN reported ISOVORIN problem on Apr 14, 2008. Female patient, 48 years of age, weighting 103.6 lb, was diagnosed with colon cancer and was treated with ISOVORIN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, . ISOVORIN dosage: 200 MG/M2. During the same period patient was treated with DECADRON, KYTRIL, AVASTIN, FLUOROURACIL, ELPLAT. Patient recovered.
Avastin Side Effects Report #5719585-8
AVASTIN problem was reported by a Physician from UNITED STATES on Apr 23, 2007. Male patient, 75 years of age, was diagnosed with colorectal cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, . AVASTIN dosage: unknown. During the same period patient was treated with XELODA, OXALIPLATIN, AVODART, FLOMAX, METOPROLOL TARTRATE. Patient was hospitalized. Patient died on 03/21/2007.
Avastin Side Effects Report #5719683-9
Physician from UNITED STATES reported AVASTIN problem on Mar 12, 2007. Male patient, 70 years of age, weighting 153.9 lb, was diagnosed with non-small cell lung cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, pneumonia aspiration, sepsis, . AVASTIN dosage: 1048 MG, DAYS 1+22, INTRAVENOUS. During the same period patient was treated with TAXOL, CARBOPLATIN. Patient died on 01/13/2007.
Avastin Side Effects Report #5720069-1
AVASTIN problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 12, 2007. Female patient, 56 years of age, weighting 180.8 lb, was diagnosed with glioblastoma, glioma and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, . AVASTIN dosage: 930 MG, Q15D, INTRAVENOUS. During the same period patient was treated with KEPPRA, DEXAMETHASONE, ZOFRAN. Patient was hospitalized. Patient recovered.
Avastin Side Effects Report #5720072-1
Pharmacist from UNITED STATES reported AVASTIN problem on Sept 26, 2007. Male patient, 80 years of age, weighting 165.3 lb, was diagnosed with renal cell carcinoma and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, . AVASTIN dosage: 740 MG, Q2W, INTRAVENOUS. During the same period patient was treated with TORISEL, DIPHENHYDRAMINE. Patient was hospitalized. Patient died on 08/30/2007.
Avastin Side Effects Report #5720363-4
AVASTIN problem was reported by a Physician from UNITED STATES on July 10, 2007. Male patient, 69 years of age, was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, . AVASTIN dosage: unknown. Patient recovered.
Avastin Side Effects Report #5720476-7
Physician from UNITED STATES reported AVASTIN problem on Apr 16, 2007. Female patient, 71 years of age, weighting 192.0 lb, was diagnosed with ovarian cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, . AVASTIN dosage: unknown. During the same period patient was treated with TOPOTECAN. Patient was hospitalized. Patient recovered.
Avastin Side Effects Report #5720478-0
AVASTIN problem was reported by a Physician from UNITED STATES on June 04, 2007. Female patient, 63 years of age, was diagnosed with breast cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, . AVASTIN dosage: unknown. During the same period patient was treated with ABRAXANE. Patient recovered.
Avastin Side Effects Report #5720507-4
Consumer or non-health professional from UNITED STATES reported AVASTIN problem on Jan 24, 2008. Female patient, 29 years of age, was diagnosed with ovarian cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, . AVASTIN dosage: unknown. Patient died.
Avastin Side Effects Report #5338011-4
AVASTIN problem was reported by a Physician from UNITED STATES on Feb 06, 2007. Male patient, 70 years of age, weighting 153.9 lb, was diagnosed with non-small cell lung cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, . AVASTIN dosage: 1048 MG, DAYS 1+22, INTRAVENOUS. During the same period patient was treated with TAXOL, CARBOPLATIN. Patient recovered.
Avastin Side Effects Report #5338238-1
Physician from UNITED STATES reported AVASTIN problem on Jan 18, 2007. Male patient was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, . AVASTIN dosage: 5 MG/KG. Patient recovered.
Avastin Side Effects Report #5338273-3
AVASTIN problem was reported by a Physician from UNITED STATES on Feb 12, 2007. Female patient, 52 years of age, weighting 123.0 lb, was diagnosed with colon cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, septic shock, . AVASTIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM, OXALIPLATIN. Patient was hospitalized. Patient recovered.
Indocin Side Effects Report #5338882-1
Pharmacist from UNITED STATES reported INDOCIN I problem on Jan 23, 2007. Male patient, weighting 1.41 lb, was diagnosed with patent ductus arteriosus and was treated with INDOCIN I. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, . INDOCIN I dosage: 0.13 MG; Q12J; IV. During the same period patient was treated with BROAD SPECTRUM ANTIBIOTICS. Patient recovered.
Taxol Side Effects Report #5254547-9
TAXOL problem was reported by a Physician from JAPAN on Feb 28, 2007. Male patient, 41 years of age, was diagnosed with non-small cell lung cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, . TAXOL dosage: unknown. During the same period patient was treated with PARAPLATIN, SORAFENIB, DECADRON, RESTAMIN, ZANTAC, KYTRIL, VOLTAREN. Patient was hospitalized. Patient recovered.
Taxotere Side Effects Report #5254968-4
Physician from JAPAN reported TAXOTERE problem on Feb 23, 2007. Female patient, 53 years of age, was diagnosed with breast cancer and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, . TAXOTERE dosage: DOSE: 75 MG/M2. During the same period patient was treated with HERCEPTIN. Patient died.
Taxotere Side Effects Report #5263490-0
TAXOTERE problem was reported by a Physician from JAPAN on Mar 08, 2007. Female patient, 53 years of age, weighting 136.7 lb, was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, pleural effusion, . TAXOTERE dosage: unknown. During the same period patient was treated with HERCEPTIN, LOXOPROFEN, OXYCONTIN, DECADRON. Patient died on 08/03/2006.
Avastin Side Effects Report #5661452-2
Physician from UNITED KINGDOM reported AVASTIN problem on Feb 27, 2008. Male patient, weighting 132.3 lb, was diagnosed with colon cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: ascites, gastrointestinal perforation, neoplasm progression, oedema, . AVASTIN dosage: unknown. During the same period patient was treated with CAPECITABINE, OXALIPLATIN. Patient was hospitalized. Patient recovered.